Genomics Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Genomics stocks.

Genomics Stocks Recent News

Date Stock Title
Nov 21 IBRX ImmunityBio and nCartes Enter Collaboration Agreement on Clinical Trial Data Fulfillment
Nov 21 QSI Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event
Nov 20 ILMN Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
Nov 20 CTKB Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference
Nov 20 ILMN If RFK Jr. Cuts Science Funding, These Instrument Makers May Suffer
Nov 20 ILMN Illumina, Inc. (ILMN) CFO Ankur Dhingra Hosts Wolfe Research 2024 Healthcare Conference (Transcript)
Nov 20 QSI Crude Oil Moves Lower; Williams-Sonoma Shares Gain After Q3 Results
Nov 20 IBRX High Growth Tech Stocks To Watch In November 2024
Nov 20 ILMN Illumina gear up to expand TruSight Oncology portfolio
Nov 20 QSI Avantor to Distribute Quantum-Si’s Next-Generation Protein Sequencing™ Technology
Nov 20 ILMN ILMN Stock Set to Gain From Expansion of TruSight Oncology Portfolio
Nov 20 QSI Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration with NVIDIA
Nov 20 QSI Quantum-Si Expands Collaboration with SkyWater to Develop New Chip Production Process Critical for Groundbreaking New Proteomics Platform
Nov 20 QSI Quantum-Si and Planet Innovation to Partner on Proteus™
Nov 19 CTKB Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
Nov 19 ILMN Illumina announces expansion of TruSight Oncology portfolio
Nov 19 WGS GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover
Nov 19 NEO NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
Nov 19 IBRX ImmunityBio Completes ANKTIVA’s Post-Approval Enrollment of the 100th Patient in BCG Unresponsive NMIBC CIS Trial and Reports a Complete Response Rate of 71% with a Durable Duration of Response Ranging Up to 54 Months
Nov 18 QSI Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Genomics

Genomics is an interdisciplinary field of science focusing on the structure, function, evolution, mapping, and editing of genomes. A genome is an organism's complete set of DNA, including all of its genes. In contrast to genetics, which refers to the study of individual genes and their roles in inheritance, genomics aims at the collective characterization and quantification of genes, which direct the production of proteins with the assistance of enzymes and messenger molecules. In turn, proteins make up body structures such as organs and tissues as well as control chemical reactions and carry signals between cells. Genomics also involves the sequencing and analysis of genomes through uses of high throughput DNA sequencing and bioinformatics to assemble and analyze the function and structure of entire genomes. Advances in genomics have triggered a revolution in discovery-based research and systems biology to facilitate understanding of even the most complex biological systems such as the brain.The field also includes studies of intragenomic (within the genome) phenomena such as epistasis (effect of one gene on another), pleiotropy (one gene affecting more than one trait), heterosis (hybrid vigour), and other interactions between loci and alleles within the genome.

Browse All Tags